{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:13:39Z","timestamp":1788873219891,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":60,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004913","name":"Universit\u00e0 degli Studi di Palermo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004913","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Aging Clin Exp Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hyperhomocysteinemia, an elevation of plasma homocysteine levels, has been implicated in multiple diseases, yet its causal role remains debated. This umbrella review systematically evaluated and graded the evidence from published systematic reviews and meta-analyses on associations between hyperhomocysteinemia and diverse health outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched Medline, Embase, and Web of Science up to March 5, 2025. Eligible studies were systematic reviews and meta-analyses of observational studies reporting associations between hyperhomocysteinemia and any health outcome. Methodological quality was assessed using AMSTAR-2, and the certainty of evidence was graded using GRADE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 104 meta-analyses including 2,110 studies and 953,793 participants were analyzed, covering 126 outcomes. Eighty-three percent of outcomes showed significant associations with hyperhomocysteinemia. Nine outcomes were supported by high, 18 by moderate, 73 by low, and 26 by very low certainty of evidence. High-certainty evidence supported associations between hyperhomocysteinemia and increased risks of stroke, intracerebral haemorrhage, fracture (hip and total), and chronic kidney disease. Moderate-certainty evidence linked hyperhomocysteinemia to dementia, Alzheimer\u2019s disease, mortality, and selected cardiovascular and pregnancy outcomes. Most meta-analyses were of low or critically low methodological quality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Across nearly one million participants, hyperhomocysteinemia was consistently associated with adverse health outcomes, particularly vascular, neurological, skeletal, and renal conditions. While causality cannot be inferred, the evidence supports hyperhomocysteinemia as a potentially modifiable risk factor meriting targeted preventive and interventional research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Protocol registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/osf.io\/dezms\" ext-link-type=\"uri\">https:\/\/osf.io\/dezms<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s40520-026-03433-0","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T11:04:39Z","timestamp":1783681479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hyperhomocysteinemia, a risk factor for various health conditions: an umbrella review of systematic reviews with meta-analysis"],"prefix":"10.1007","volume":"38","author":[{"given":"Alberto","family":"Castagna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino Maria","family":"Cotroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Mosele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"Sapone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Rahmati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3433_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12986-017-0233-z","volume":"14","author":"A Kumar","year":"2017","unstructured":"Kumar A, Palfrey HA, Pathak R et al (2017) The metabolism and significance of homocysteine in nutrition and health. Nutr Metab (Lond) 14:78","journal-title":"Nutr Metab (Lond)"},{"key":"3433_CR2","doi-asserted-by":"publisher","first-page":"2948","DOI":"10.2174\/0929867325666180313105949","volume":"26","author":"BL Zaric","year":"2019","unstructured":"Zaric BL, Obradovic M, Bajic V et al (2019) Homocysteine and hyperhomocysteinaemia. Curr Med Chem 26:2948\u20132961","journal-title":"Curr Med Chem"},{"key":"3433_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2025.100434","volume":"16","author":"F Zhou","year":"2025","unstructured":"Zhou F, He Y, Xie X et al (2025) Homocysteine and multiple health outcomes: an outcome-wide umbrella review of meta-analyses and Mendelian randomization studies. Adv Nutr 16:100434","journal-title":"Adv Nutr"},{"key":"3433_CR4","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12031-015-0497-6","volume":"56","author":"H-J Fu","year":"2015","unstructured":"Fu H-J, Zhao L-B, Xue J-J et al (2015) Elevated serum homocysteine (Hcy) levels may contribute to the pathogenesis of cerebral infarction. J Mol Neurosci 56:553\u2013561","journal-title":"J Mol Neurosci"},{"key":"3433_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1177\/000331970605700102","volume":"57","author":"MS Kazemi","year":"2006","unstructured":"Kazemi MS, Eshraghian K, Omrani G et al (2006) Homocysteine level and coronary artery disease. Angiology 57:9\u201314","journal-title":"Angiology"},{"key":"3433_CR6","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1056\/NEJMoa011613","volume":"346","author":"S Seshadri","year":"2002","unstructured":"Seshadri S, Beiser A, Selhub J et al (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease. N Engl J Med 346:476\u2013483","journal-title":"N Engl J Med"},{"key":"3433_CR7","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1136\/bmj.316.7135.894","volume":"316","author":"Collaboration HLT","year":"1998","unstructured":"Collaboration HLT (1998) Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. BMJ 316:894\u2013898","journal-title":"BMJ"},{"key":"3433_CR8","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2016.11.003","volume":"53","author":"L Hannibal","year":"2017","unstructured":"Hannibal L, Blom HJ (2017) Homocysteine and disease: causal associations or epiphenomenons? Mol Aspects Med 53:36\u201342","journal-title":"Mol Aspects Med"},{"key":"3433_CR9","doi-asserted-by":"publisher","DOI":"10.1177\/1179573520962230","volume":"12","author":"F Al Mutairi","year":"2020","unstructured":"Al Mutairi F (2020) Hyperhomocysteinemia: clinical insights. J Cent Nerv Syst Dis 12:1179573520962230","journal-title":"J Cent Nerv Syst Dis"},{"key":"3433_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/9781119536604","volume-title":"Cochrane handbook for systematic reviews of interventions","author":"JP Higgins","year":"2019","unstructured":"Higgins JP, Thomas J, Chandler J et al (2019) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons"},{"key":"3433_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13643-021-01626-4","volume":"10","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev 10:1\u201311","journal-title":"Syst Rev"},{"key":"3433_CR12","doi-asserted-by":"publisher","DOI":"10.1080\/15424065.2025.2547027","volume-title":"Covidence","author":"M Hupe","year":"2025","unstructured":"Hupe M (2025) Covidence. Taylor & Francis"},{"key":"3433_CR13","doi-asserted-by":"crossref","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, Moher D, Tugwell P, Welch V, Kristjansson E (2017) AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. bmj 358:","DOI":"10.1136\/bmj.j4008"},{"key":"3433_CR14","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","volume":"336","author":"GH Guyatt","year":"2008","unstructured":"Guyatt GH, Oxman AD, Vist GE et al (2008) GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336:924","journal-title":"BMJ"},{"key":"3433_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2174\/1389200052997357","volume":"6","author":"N Weiss","year":"2005","unstructured":"Weiss N (2005) Mechanisms of increased vascular oxidant stress in hyperhomocysteinemia and its impact on endothelial function. Curr Drug Metab 6:27\u201336","journal-title":"Curr Drug Metab"},{"key":"3433_CR16","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1089\/ars.2007.1750","volume":"9","author":"L Papatheodorou","year":"2007","unstructured":"Papatheodorou L, Weiss N (2007) Vascular oxidant stress and inflammation in hyperhomocysteinemia. Antioxid Redox Signal 9:1941\u20131958","journal-title":"Antioxid Redox Signal"},{"key":"3433_CR17","first-page":"1","volume-title":"Hemostasis in surgery","author":"A Shlebak","year":"2007","unstructured":"Shlebak A (2007) Pathophysiological aspects of coagulation. In: Hakim NS, Calero R (eds) Hemostasis in surgery. Imperial College Press, London, pp 1\u201390"},{"key":"3433_CR18","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1001\/jama.2015.2274","volume":"313","author":"Y Huo","year":"2015","unstructured":"Huo Y, Li J, Qin X et al (2015) Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial. JAMA 313:1325\u20131335","journal-title":"JAMA"},{"key":"3433_CR19","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1016\/j.clnu.2024.05.034","volume":"43","author":"N Zhang","year":"2024","unstructured":"Zhang N, Zhou Z, Chi X et al (2024) Folic acid supplementation for stroke prevention: a systematic review and meta-analysis of 21 randomized clinical trials worldwide. Clin Nutr 43:1706\u20131716","journal-title":"Clin Nutr"},{"key":"3433_CR20","doi-asserted-by":"crossref","unstructured":"Sharma DK, Cheok TS, Rogers M, Lu VYZ, Solomon LB, Ramasamy B, Clifton PM, Callary SA (2025) RELATIONSHIP BETWEEN HOMOCYSTEINE LEVELS AND BONE QUALITY IN HEALTHY ADULTS-A SYSTEMATIC REVIEW AND META-ANALYSIS. Clinical Nutrition ESPEN","DOI":"10.1016\/j.clnesp.2025.06.034"},{"key":"3433_CR21","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3945\/ajcn.114.090043","volume":"100","author":"JP van Wijngaarden","year":"2014","unstructured":"van Wijngaarden JP, Swart KM, Enneman AW et al (2014) Effect of daily vitamin B-12 and folic acid supplementation on fracture incidence in elderly individuals with an elevated plasma homocysteine concentration: B-PROOF, a randomized controlled trial. Am J Clin Nutr 100:1578\u20131586","journal-title":"Am J Clin Nutr"},{"key":"3433_CR22","unstructured":"Sharma U (2025) Nutritional management of pediatric nephrotic syndrome regarding oxidative stress and. Foods, Dietary Supplements, and Herbal Products Treating the Diseases of the 21st Century: Moving from Traditional to Scientific Research, volume II"},{"key":"3433_CR23","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1016\/j.febslet.2006.04.088","volume":"580","author":"R Obeid","year":"2006","unstructured":"Obeid R, Herrmann W (2006) Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett 580:2994\u20133005","journal-title":"FEBS Lett"},{"key":"3433_CR24","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1002\/alz.13884","volume":"20","author":"APM van Soest","year":"2024","unstructured":"van Soest APM, de Groot L, Witkamp RF et al (2024) Concurrent nutrient deficiencies are associated with dementia incidence. Alzheimers Dement 20:4594\u20134601","journal-title":"Alzheimers Dement"},{"key":"3433_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012244","volume":"5","author":"AD Smith","year":"2010","unstructured":"Smith AD, Smith SM, De Jager CA et al (2010) Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 5:e12244","journal-title":"PLoS ONE"},{"key":"3433_CR26","doi-asserted-by":"publisher","first-page":"9523","DOI":"10.1073\/pnas.1301816110","volume":"110","author":"G Douaud","year":"2013","unstructured":"Douaud G, Refsum H, de Jager CA et al (2013) Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment. Proc Natl Acad Sci U S A 110:9523\u20139528","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3433_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s12012-023-09819-0","volume":"24","author":"S Shibeeb","year":"2024","unstructured":"Shibeeb S, Abdallah A, Shi Z (2024) Blood homocysteine levels mediate the association between blood lead levels and cardiovascular mortality. Cardiovasc Toxicol 24:62\u201370","journal-title":"Cardiovasc Toxicol"},{"key":"3433_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3720684","author":"J Xu","year":"2018","unstructured":"Xu J, Zhao X, Sun S et al (2018) Homocysteine and digestive tract cancer risk: a dose-response meta-analysis. J Oncol. https:\/\/doi.org\/10.1155\/2018\/3720684","journal-title":"J Oncol"}],"container-title":["Aging Clinical and Experimental Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40520-026-03433-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-026-03433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40520-026-03433-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T13:04:39Z","timestamp":1788872679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40520-026-03433-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3433"],"URL":"https:\/\/doi.org\/10.1007\/s40520-026-03433-0","relation":{},"ISSN":["1720-8319"],"issn-type":[{"value":"1720-8319","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"1 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests. Nicola Veronese is Editor in Chief of Aging Clinical Experimental Research.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"183"}}